Penn Radiology Oncologic Imaging Optimizing Patient Care 2016
Penn Radiology joins forces with its experts in Nuclear Medicine, Gastroenterology, Pulmonology, Radiation and Interventional Oncology to present this comprehensive review of Oncologic Imaging. Best practices and clinical correlates will be discussed, with two detailed sessions dedicated to CT screening for lung cancer. Credits for this program can be applied toward your Self Assessment CME Requirements for ABR Maintenance of Certification.
Topics: CT Screening for Lung Cancer, State of the Art and Emerging Techniques, Heck and Neck Cancer, Thoracic, GI and other Abdominal Malignancies, Neuroendocrine Tumors, Lymphoma, Melanoma and MSK.
Session 1: Current State-of-the-Art and Emerging Techniques
| MRI State-of-the-Art and Emerging Applications | Mark A. Rosen, MD, PhD |
| CT State-of-the-Art and Emerging Applications | Susan Hilton, MD |
| US State-of-the Art and Emerging Applications | Steven C. Horii, MD, FACR, FSIIM |
| SPECT/CT and PET/CT State-of-the Art and Emerging Applications | Daniel A. Pryma, MD |
| Tomosynthesis: Technique, Current and Emerging Applications | Emily F. Conant, MD |
Session 2: Head and Neck Cancers
| Evaluation of Sinonasal and Skullbase Neoplasia | Laurie A. Loevner, MD |
| The Role of Ultrasound in Detecting Thyroid Cancer | Hanna M. Zafar, MD |
| Imaging of Laryngeal Cancer | Laurie A. Loevner, MD |
Session 3: CT Screening for Lung Cancer 1
| CT Screening for Lung Cancer: Rationale and Evidence Base | Drew A. Torigian, MD, MA |
| Establishing a Successful Lung Cancer Screening Program | Ana S. Kolansky, MD |
| Screening CT: Optimizing Scan Techniques and Reporting | Eduardo M. Barbosa, MD |
| ACR LungRADS: Structured Nodule Reporting and Management System | Ana S. Kolansky, MD |
Session 4: CT Screening for Lung Cancer 2
| Risk/Benefit & Over-diagnosis in Lung Cancer Screening | Eduardo M. Barbosa, MD |
| Patient Conversations: Shared Decision Making and Counseling | Anil Vachani, MD |
| Future Directions in the Screening of Lung Cancer | Anil Vachani, MD |
| Case Presentations and Panel Discussion | Multiple Faculty Members |
Session 5: Clinical Updates and Imaging Correlates
| Medical Oncology: Update on Immune-modulating Therapeutics and Imaging Correlates | Tara C. Gangadhar, MD |
| AJCC Staging, Standard of Care Therapy, Breast and Gynecologic Malignancies | Lilie Lin, MD |
| Imaging of Gynecologic Cancers: Focus on Treatment Planning | Lilie Lin, MD |
Session 6: Thoracic Malignancies
| Ultrasound in Breast Imaging | Susan Roth, MD |
| Indications for MR Imaging of the Breast | Susan Roth, MD |
| Lung Cancer Staging, Standard of Care and Imaging Strategies | Drew A. Torigian, MD, MA |
Session 7: GI Malignancies
| Esophageal & Gastric Cancer: AJCC Update and Standard of Care | Daniel A. Pryma, MD |
| Fluorscopy After Oncologic GI Surgery | Stephen E. Rubesin, MD |
| CT Colonography, Techniques, Interpretations and Reimbursement | Hanna M. Zafar, MD |
Session 8: Other Abdominal Malignancies
| Liver Imaging for Primary and Metastic Disease (MR) | Anil Chauhan, MD |
| Liver Directed Therapy: Treatment Options, Technical Aspects and Work-up | Deepak Sudheendra, MD, RPVI |
| Prostate Cancer: Initial Imaging Work-up and Imaging in the Face of Rising PSA | Anil Chauhan, MD |
| Prostate Cancer Treatment Options and Toxicities | Daniel A. Pryma, MD |
| Renal Masses and Cancers: Imaging Work-up, Biopsies and Surgical Approaches | Nicholas Papanicolaou, MD |
Session 9: Neuroendocrine Tumors
| Neuroendocrine Tumors: Work-up, Symptoms and Palliative Options | David C. Metz, MD |
| Neuroendocrine Tumors: Chemotherapeutic Options and Imaging Implications | Arturo Loaiza-Bonilla, MD |
| Radiopharmaceutical Imaging and Therapy of Neuroendocrine Tumors | Daniel A. Pryma, MD |
Session 10: GI Malignancies
| Lymphoma Imaging, Treatments and Follow-up | Jakub Svoboda, MD |
| Image-guided Adaptive Therapy in Lymphoma | David A. Mankoff, MD, PhD |
| Melanoma: Review of Staging and Treatment Options | Daniel A. Pryma, MD |
| Melanoma: Patterns of Recurrence and Toxicity in the Era of Immune-modulating Therapy | David A. Mankoff, MD, PhD |
| Musculoskeletal Malignancies: Imaging Patterns, Treatments and Pitfalls | Madhura A. Desai, MD, PhD |
Release Date: 2/15/16
